Contacare, Inc. v. CIBA-Geigy Corp.Contacare, Inc. v. CIBA-Geigy Corp.
Memorandum: Plaintiff commenced this breach of contract and fraud action seeking royalties based on defendant’s alleged use of plaintiff’s technology for extended wear soft contact
The first cause of action, for breach of contract, alleged that defendant had marketed TC-75 lenses or minor derivations thereof but had not compensated plaintiff for that use of the technology pursuant to the license agreement. Defendant met its initial burden on the motion with respect to the first cause of action by submitting evidence establishing that the lenses produced by defendant were not derivations of TC-75, and plaintiff failed to raise a triable issue of fact in opposition (see generally Zuckerman v City of New York,
In the third cause of action, for fraud, plaintiff alleged that defendant had a duty to use its best effort to exploit the TC-75 technology, that defendant falsely represented that it would fulfill that duty, and that Trans-Canada relied on that representation in entering into the license agreement. A necessary element of a fraud cause of action is a misrepresentation of a material fact (see Small v Lorillard Tobacco Co.,
Article 2.1 of the license agreement expressly provided that Trans-Canada granted to CIBA “a perpetual worldwide nonexclusive license, with the right to grant sublicenses, to practice the Know-How.” Nevertheless, plaintiff contended that the license agreement was exclusive based on article 8.1, which provided that Trans-Canada “agrees to disclose the Know-How to [CIBA] and not to third parties.” Those two provisions cannot be interpreted in a way to avoid the inconsistency (cf. Comprehensive Health Solutions v Trustco Bank, N.A.,
The court properly concluded that article 2.1 was controlling, based on the court’s review of the option agreement and attached exhibits, and thus properly concluded that the license agreement was not exclusive. CIBA exercised its option to enter into the license agreement set forth as exhibit B to the option agreement, rather than the license agreement set forth as exhibit A. A comparison of the two proposed license agreements demonstrates that exhibit A was the exclusive license agreement, whereas exhibit B was the nonexclusive license agreement. Article 2.1 of exhibit A defined the license as “exclusive,” and a comparison of article 3 of each of the two exhibits demonstrates that CIBA was to pay more royalties to Trans-Canada under exhibit A’s exclusive license agreement. Article 8.1 of each of the two exhibits was identical, which suggests that the language of exhibit A was inadvertently copied into exhibit B. Plaintiff contends that the court should not have considered exhibit A in interpreting the executed license agreement because exhibit A was not executed by the parties. Exhibit A, however, was part of the executed option agreement, and the court properly considered the option agreement in interpreting the license agreement because the documents were part of the same transaction (see Nau v Vulcan Rail & Constr. Co.,